SHC Share Price Performance
US$13.50
1.29 (10.57%)
34.9% undervalued intrinsic discount
US$20.75
Fair Value
Price US$13.50
AnalystConsensusTarget US$20.75
AnalystHighTarget US$24.00
AnalystLowTarget US$16.00
Fair ValueUS$20.75
Share Pricen/a
Sotera Health Company Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
SHC Community Narratives
AN
Fair Value US$20.75 34.9% undervalued intrinsic discount
SHC: Recent Equity Offerings And Lock-Up Expiry Will Shape Market Outlook
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value US$24 43.8% undervalued intrinsic discount
Bullish View Expects Sterilization Demand And Cobalt 60 Stability To Support Long-Term Upside
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$16 15.6% undervalued intrinsic discount
Ethylene Oxide Litigation And Regulatory Costs Will Constrain Long Term Prospects
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
SHC: Recent Equity Offerings And Lock-Up Expiry Will Shape Market Outlook
Key Takeaways Growing sterilization and lab testing demand, expanded capacity, and regulatory tailwinds will drive revenue growth, margin expansion, and overall earnings stability. Cash flow strength, long-term contracts, and lower debt enhance revenue predictability and provide flexibility for future growth investments.Read more
124
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
US$20.75
34.9% undervalued intrinsic discount
Fair Value
Revenue
6.21% p.a.
Profit Margin
20.1%
Future PE
27.44x
Price in 2029
US$26.89
Bullish View Expects Sterilization Demand And Cobalt 60 Stability To Support Long-Term Upside
Catalysts About Sotera Health Sotera Health provides sterilization services and lab testing that support global health care and medical products. What are the underlying business or industry changes driving this perspective?Read more
1
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$24
43.8% undervalued intrinsic discount
Fair Value
Revenue
6.94% p.a.
Profit Margin
18.31%
Future PE
34.26x
Price in 2029
US$30.99
Ethylene Oxide Litigation And Regulatory Costs Will Constrain Long Term Prospects
Catalysts About Sotera Health Sotera Health provides sterilization and lab testing services that support medical devices, bioprocessing and other health care products. What are the underlying business or industry changes driving this perspective?Read more
1
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$16
15.6% undervalued intrinsic discount
Fair Value
Revenue
6.38% p.a.
Profit Margin
18.44%
Future PE
23.04x
Price in 2029
US$20.66
Trending Discussion
Recently Updated Narratives
AN
SHC: Organic Investment And Margin Expansion Will Support Future Upside Potential
Fair Value: US$20.75 34.9% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Bullish View Expects Sterilization Demand And Cobalt 60 Stability To Support Long-Term Upside
Fair Value: US$24 43.8% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Ethylene Oxide Litigation And Regulatory Costs Will Constrain Long Term Prospects
Fair Value: US$16 15.6% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Sotera Health Company Key Details
About SHC
- Founded
- 2015
- Employees
- 3000
- CEO
- WebsiteView website
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.
